Newborn jaundice and kernicterus—health and societal perspectives
- 1 May 2003
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 70 (5) , 407-416
- https://doi.org/10.1007/bf02723615
Abstract
Kernicterus, a preventable injury to the brain from severe neonatal jaundice, has re-emerged in the United States as a public and societal health concern. Kernicterus, in its usually recognized form, causes devastating disabilities, including athetoid cerebral palsy and speech and hearing impairment. This condition not only ranks amongst the highest cost per new case (per CDC’s Financial Burden of Disability study, 1992), but also results in profound and uncompromising grief for the family and loss to siblings of healthy, talkative playmates. And for the child with kernicterus (usually remarkably intelligent, but trapped in an uncontrollable body), grief and frustration are enormous. In 2001 national healthcare organizations, including Centers for Disease Control (CDC), the Joint Commission for the Accreditation of Healthcare Organizations (JACHO) and the American Academy of Pediatrics (AAP) issued alerts to all accredited hospitals and public health professionals in the United States that all healthy infants are at potential risk of kernicterus if their newborn jaundice is unmonitored and inadequately treated. The re-emergence of kernicterus in the United States is the result of interacting phenomena including (a) Early hospital discharge (before extent of jaundice is known and signs of impending brain damage have appeared); (b) Lack of adequate concern for the risks of severe jaundice in healthy term and near newborns; (c) An increase in breast feeding; (d) Medical care cost constraints; (e) Paucity of educational materials to enable parents to participate in safeguarding their newborns; and (f) Limitations within in healthcare systems to monitor the outpatient progression of jaundice. A multidisciplinary approach that encompasses both healthcare and societal needs should be evaluated at a national level for practical and easy to implement strategies. An approach that is based on principles of evidence-based medicine, patient-safety and family centeredness is presented in this article. These strategies should also be based on public awareness campaign such that the healthcare providers can attempt to achieve a “Zero Tolerance of Kernicterus” and thereby decrease both childhood disabilities and infant mortality within the community.Keywords
This publication has 23 references indexed in Scilit:
- Preventing kernicterus: Almost thereThe Journal of Pediatrics, 2002
- System-based approach to management of neonatal jaundice and prevention of kernicterusThe Journal of Pediatrics, 2002
- Are Moderate Degrees of Hyperbilirubinemia in Healthy Term Neonates Really Safe for the Brain?Pediatric Research, 2001
- Neonatal hyperbilirubinemia and the potential risk of subtle neurological dysfunction.Pediatric Research, 2001
- Bilirubin and neurological dysfunction--do we need to change what we are doing?Pediatric Research, 2001
- Just When You Thought It Was Safe…: Commentary on the article by Soorani-Lunsing et al. on page 701Pediatric Research, 2001
- Jaundice Technologies: Prediction of Hyperbilirubinemia in Term and Near-Term NewbornsJournal of Perinatology, 2001
- Neonatal Jaundice and KernicterusPediatrics, 2001
- A Single Dose of Sn-Mesoporphyrin Prevents Development of Severe Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-Deficient NewbornsPediatrics, 2001
- Prediction of Hyperbilirubinemia in Near-Term and Term InfantsPediatrics, 2001